Effects of Empagliflozin and Lifestyle Intervention on Improving Body Weight and Other Metabolic Parameters in Atypical Antipsychotics-treated Patients with Schizophrenia Spectrum Disorders-A Double-blind Randomized Placebo-controlled Trial.

Wong SY et al.

NCBI PubMed Central · Papers · License: Open Access

cognitive psychology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 170474
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.